tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics (DE:9IB)
:9IB
Advertisement

Infant Bacterial Therapeutics AB (9IB) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Infant Bacterial Therapeutics AB
€4.23
€57.79M
-50.12%
SynAct Pharma AB
€1.86
€94.20M
173.24%
Saniona AB
€0.79
€112.07M
4.69
192.59%
0 Buy
0 Hold
0 Sell
Moderate Buy
IRLAB Therapeutics AB Class A
€0.31
€28.10M
-75.97%
0 Buy
0 Hold
0 Sell
Hold
Xspray Pharma AB
€4.79
€172.82M
-29.04%
Cantargia AB
€0.31
€85.23M
-13.33%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:9IB
Infant Bacterial Therapeutics AB
4.22
-4.24
-50.12%
DE:8F8
SynAct Pharma AB
1.86
1.16
165.71%
DE:30S
Saniona AB
0.79
0.53
203.85%
DE:6IRA
IRLAB Therapeutics AB Class A
0.31
-0.98
-75.97%
DE:6XP
Xspray Pharma AB
4.79
-1.83
-27.64%
DE:7V3
Cantargia AB
0.31
-0.05
-13.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis